Clinical Trial Update: A Study of Single and Multiple Doses HRS9531 Tablets in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study assessing single and multiple doses of HRS9531 tablets in healthy subjects to evaluate safety and pharmacokinetics, with overweight/obesity and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• HRS9531

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Overweight or Obesity; Type 2 Diabetes | Phase 1 | Status: COMPLETED